212 related articles for article (PubMed ID: 17204153)
21. Extracellular microvesicles-derived from microglia treated with unaggregated α-synuclein attenuate mitochondrial fission and toxicity-induced by Parkinsonian toxin MPP
Li N; Wu Y; Zhu L; Huang Y; Liu Z; Shi M; Soltys D; Zhang J; Chang Q
Biochem Biophys Res Commun; 2019 Oct; 517(4):642-647. PubMed ID: 31402119
[TBL] [Abstract][Full Text] [Related]
22. Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1.
Lee EJ; Woo MS; Moon PG; Baek MC; Choi IY; Kim WK; Junn E; Kim HS
J Immunol; 2010 Jul; 185(1):615-23. PubMed ID: 20511551
[TBL] [Abstract][Full Text] [Related]
23. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.
Qian L; Xu Z; Zhang W; Wilson B; Hong JS; Flood PM
J Neuroinflammation; 2007 Sep; 4():23. PubMed ID: 17880684
[TBL] [Abstract][Full Text] [Related]
24. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease.
Park JY; Paik SR; Jou I; Park SM
Glia; 2008 Aug; 56(11):1215-23. PubMed ID: 18449945
[TBL] [Abstract][Full Text] [Related]
25. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD.
Chang C; Lang H; Geng N; Wang J; Li N; Wang X
Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198
[TBL] [Abstract][Full Text] [Related]
26. Nitrated alpha-synuclein and microglial neuroregulatory activities.
Reynolds AD; Kadiu I; Garg SK; Glanzer JG; Nordgren T; Ciborowski P; Banerjee R; Gendelman HE
J Neuroimmune Pharmacol; 2008 Jun; 3(2):59-74. PubMed ID: 18202920
[TBL] [Abstract][Full Text] [Related]
27. Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity.
Shie FS; Breyer RM; Montine TJ
Am J Pathol; 2005 Apr; 166(4):1163-72. PubMed ID: 15793296
[TBL] [Abstract][Full Text] [Related]
28. Integrin CD11b mediates α-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway.
Hou L; Bao X; Zang C; Yang H; Sun F; Che Y; Wu X; Li S; Zhang D; Wang Q
Redox Biol; 2018 Apr; 14():600-608. PubMed ID: 29154191
[TBL] [Abstract][Full Text] [Related]
29. Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy.
Choi I; Heaton GR; Lee YK; Yue Z
Sci Adv; 2022 Oct; 8(43):eabn1298. PubMed ID: 36288297
[TBL] [Abstract][Full Text] [Related]
30. Preferential microglial activation associated with pathological alpha synuclein transmission.
Kim YE; Lai TT; Kim YJ; Jeon B
J Clin Neurosci; 2020 Nov; 81():469-476. PubMed ID: 33222964
[TBL] [Abstract][Full Text] [Related]
31. Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates.
Valdinocci D; Grant GD; Dickson TC; Pountney DL
Mol Cell Neurosci; 2018 Jun; 89():80-94. PubMed ID: 29673913
[TBL] [Abstract][Full Text] [Related]
32. Clearance and deposition of extracellular alpha-synuclein aggregates in microglia.
Lee HJ; Suk JE; Bae EJ; Lee SJ
Biochem Biophys Res Commun; 2008 Aug; 372(3):423-8. PubMed ID: 18492487
[TBL] [Abstract][Full Text] [Related]
33. Identification of proteins involved in microglial endocytosis of alpha-synuclein.
Liu J; Zhou Y; Wang Y; Fong H; Murray TM; Zhang J
J Proteome Res; 2007 Sep; 6(9):3614-27. PubMed ID: 17676786
[TBL] [Abstract][Full Text] [Related]
34. EP2-PKA signaling is suppressed by triptolide in lipopolysaccharide-induced microglia activation.
Zhang T; Gong X; Hu G; Wang X
J Neuroinflammation; 2015 Mar; 12():50. PubMed ID: 25880276
[TBL] [Abstract][Full Text] [Related]
35. The critical role of Nramp1 in degrading α-synuclein oligomers in microglia under iron overload condition.
Wu KC; Liou HH; Kao YH; Lee CY; Lin CJ
Neurobiol Dis; 2017 Aug; 104():61-72. PubMed ID: 28476637
[TBL] [Abstract][Full Text] [Related]
36. Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models.
Wang Q; Qian L; Chen SH; Chu CH; Wilson B; Oyarzabal E; Ali S; Robinson B; Rao D; Hong JS
Brain; 2015 May; 138(Pt 5):1247-62. PubMed ID: 25716193
[TBL] [Abstract][Full Text] [Related]
37. Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease.
Thomas MP; Chartrand K; Reynolds A; Vitvitsky V; Banerjee R; Gendelman HE
J Neurochem; 2007 Jan; 100(2):503-19. PubMed ID: 17241161
[TBL] [Abstract][Full Text] [Related]
38. α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation.
Wang S; Chu CH; Stewart T; Ginghina C; Wang Y; Nie H; Guo M; Wilson B; Hong JS; Zhang J
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):E1926-35. PubMed ID: 25825709
[TBL] [Abstract][Full Text] [Related]
39. Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease.
Lee SJ
J Mol Neurosci; 2008; 34(1):17-22. PubMed ID: 18157654
[TBL] [Abstract][Full Text] [Related]
40. Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.
Kim C; Ho DH; Suk JE; You S; Michael S; Kang J; Joong Lee S; Masliah E; Hwang D; Lee HJ; Lee SJ
Nat Commun; 2013; 4():1562. PubMed ID: 23463005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
